Form ARS Marker Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR)
- The Pipeline Group Launches TPG Terminal, Giving Revenue Leaders a Single Source of Truth for Pipeline Performance
- Beyond Finance Launches Industry's First Free Clinically-Informed Financial Wellness Framework to Help Americans Create Lasting Financial Change
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
